December FDA Pipeline

Article

New molecular entities and new formulations, FDA actions and generic approvals

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
GLP-1 Medications Show Promise in Treating Hidradenitis Suppurativa

GLP-1 Medications Show Promise in Treating Hidradenitis Suppurativa

Briana Contreras
August 23rd 2025
Article

Read More

David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'

David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'

August 23rd 2025
Podcast

Listen

People With Hidradenitis Suppurativa Face More Depression and Anxiety

People With Hidradenitis Suppurativa Face More Depression and Anxiety

Briana Contreras
August 23rd 2025
Article

Read More

Nancy Lurker of EyePoint Pharmaceuticals Addresses Innovations in Eye Care, How to Grow in the C-Suite and What it Takes to Run a Biopharma Company

Nancy Lurker of EyePoint Pharmaceuticals Addresses Innovations in Eye Care, How to Grow in the C-Suite and What it Takes to Run a Biopharma Company

Briana Contreras
August 23rd 2025
Podcast

Listen

Frequent Flares Could Predict Disease Progression in Atopic Dermatitis

Frequent Flares Could Predict Disease Progression in Atopic Dermatitis

Briana Contreras
August 23rd 2025
Article

Read More

Dupixent Is Linked to a Higher Risk of Psoriasis in Patients With Atopic Dermatitis

Dupixent Is Linked to a Higher Risk of Psoriasis in Patients With Atopic Dermatitis

Briana Contreras
August 23rd 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.